• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand

    Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status

    All Eyes on Vision Health

    Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

    Vitamin D: A Fixture of Supplementation and Fortification
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    GOED Elects New Board Officers for 2023

    Aspire Hires Darrec Jones as VP of Business Development

    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women

    BAPP Paper Reviews Common Adulteration Practices Which Go Undetected

    CRN Announces Promotions and Welcomes New Staff Member
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets

    GOED Elects New Board Officers for 2023

    Lallemand Health Solutions Debuts Organic Saccharomyces Boulardii Probiotic Yeast

    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women

    BAPP Paper Reviews Common Adulteration Practices Which Go Undetected
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets

    Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand

    Aspire Hires Darrec Jones as VP of Business Development

    Lallemand Health Solutions Debuts Organic Saccharomyces Boulardii Probiotic Yeast

    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets

    Lallemand Health Solutions Debuts Organic Saccharomyces Boulardii Probiotic Yeast

    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women

    Quercetin Ingredient Linked to Improved COVID-19 Recovery: Study

    Pomegranate Extract Tied to Gut and Skin Microbiome Benefits
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Botanic Healthcare LLC

    KLK OLEO

    Chenguang Biotech Group Co., Ltd.

    Sabinsa Corporation

    Bioenergy Life Science, Inc. (BLS)
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Botanic Healthcare LLC

    KLK OLEO

    Chenguang Biotech Group Co., Ltd.

    Sabinsa Corporation

    Bioenergy Life Science, Inc. (BLS)
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    The Value of Clinical Evidence Supporting Nutraceuticals

    Consumers look for safety and efficacy, so investment in research can offer a favorable return if outcomes and quality of life are shown to improve.

    The Value of Clinical Evidence Supporting Nutraceuticals
    Related Content
    • Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand
    • Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health
    • Vitamin D: A Fixture of Supplementation and Fortification
    • NGS Begins Pilot Trial of Sports Supplement for Children
    • Battles That Have United the Natural Products Industry—and Those Which Have Not
    By Greg Stephens, Windrose Partners, and David Wilson, MA01.26.22
    In prior Business Insights columns we have offered insight on claims made for nutritional products, scientific support for product claims, and regulatory considerations for both the U.S. and internationally. In this column, Dave Wilson joins Greg Stephens to explore additional questions around evidence of clinical benefit for “nutraceuticals,” a term we use to include dietary supplements, functional foods, and vitamin and nutritional products.

    What clinical evidence is required of nutraceuticals? What evidence exists? What conclusions can be made? And what are some needs and opportunities for evidence generation in nutraceuticals?  In the U.S., evidence requirements for nutraceuticals include evaluation of safety for ingredients, which are required to be listed on the label. It is optional to make claims of clinical benefit to bring a nutraceutical to market.

    Claims and Evidence
    Claims of clinical benefit for nutraceuticals can be expressed in terms of structure/function. These claims define how the compound affects the structure or function of the human body. Companies cannot make claims that nutraceutical products “diagnose, mitigate, treat, cure, or prevent a specific disease or class of disease,” according to FDA regulations (21 USCA 343). If the company desires to do so, it has two options: 1) it can bring the product to market as a drug following drug approval regulations, or 2) it can petition the FDA for a Health Claim and show significant scientific agreement (SSA) among qualified experts that the claim is supported by the totality of publicly available scientific evidence.

    The Food and Drug Administration (FDA) has primary responsibility for claims on product labeling, including packaging, inserts, and other promotional materials distributed at the point of sale.

    The Federal Trade Commission (FTC) has primary responsibility for claims in advertising, including print and broadcast ads, infomercials, catalogs, and similar direct marketing materials. The essence of FTC guidance on dietary supplement advertising is truth in advertising: “truth-in-advertising law can be boiled down to two common-sense propositions: 1) advertising must be truthful and not misleading, and 2) before disseminating an ad, advertisers must have adequate substantiation for all objective product claims.”

    Claim substantiation by the FTC is generally viewed as flexible and does not specify quality, quantity, or methodology. FTC guidance calls for a “reasonable basis” for expressed and implied claims. Also, evaluation is “sufficiently flexible” to ensure consumers have access to products, and at the same time be “sufficiently rigorous” so consumers can have confidence in the “accuracy” of the information. What is reasonable, sufficient, or high enough accuracy for confidence is not defined. Not only is this guidance flexible, but it is also lax. 

    What Evidence Exists?
    We sought to cast a wide net in exploring what evidence of clinical benefit for nutraceuticals exists. We included expert opinion, literature review, and clinical study registry information. A targeted literature review was conducted with the search engine PubMed. We searched “dietary supplement” as a medical subject heading (MeSH term). The body of evidence is quite substantial with more than 87,000 published dietary supplement publications and over 14,000 randomized controlled trials (RCTs) (See Table 1). RCTs are the “gold standard” for proof of clinical benefit. They are required for drug approval by all the leading regulators globally. Meta-analyses combine data from studies into a single analysis for more statistical power.


    Information on clinical studies was gathered on completed and ongoing studies from ClinicalTrials.gov, a registry database of more than 390,000 medical studies conducted in about 220 countries. The database includes information on both completed and ongoing clinical studies. For the search, we entered the term “Dietary Supplement OR Nutraceutical” in the “Intervention” field. We also provide some comparisons to “Drug Interventions” searched in the same field. 

    We found more than 14,000 nutraceutical studies with a distribution of type of study like that of drug intervention studies (see Table 2). The vast majority in both cases were interventional, which are studies where participants are assigned to alternative interventions (or no intervention).
    For nutraceuticals studies, we looked at the number of studies by disease area and by nutraceutical intervention. Table 3 includes the top five in each category.

    The proportion of studies sponsored by industry for drug interventions is approximately double that for nutraceuticals (see Table 4). This was expected, given that the clinical study requirements to bring drugs to market is so much greater.
    A recent Washington Post article gathered expert opinion on dietary supplement evidence from the NIH Office of Dietary Supplements, the National Center for Complementary and Integrative Health, and the Council for Responsible Nutrition. The following question was asked in separate interviews: “Which dietary supplements actually have well established benefits?”

    Pulling together the responses, there were a total of eight dietary supplements and five vitamins and minerals that made the list. To put that in context, there are estimates of more than 85,000 supplement products in the U.S. marketplace.1 The article reached a conclusion reflected in the title: “Most dietary supplements don’t do anything. Why do we spend $35 billion a year on them?” 

    What Can Be Concluded?
    What can be concluded from clinical evidence is a broad question to which we took a broad and top-level review. 

    We evaluated systematic reviews of clinical studies of nutraceuticals; we did not conduct one. Our PubMed search (Table 1) generated 2,940 systematic reviews. We used the search term “Dietary Supplement OR Nutraceutical” in the Title or Abstract field, and narrowed that down to 175 citations. We reviewed the titles and abstracts looking for studies that spanned products and conditions. Practically all the systematic reviews focused on a specific disease area, specific product, or a combination. In our review, we only found one study that spanned products and conditions and we report the findings here.  

    Marik and Flemmer had the broad goal “to systematically review the literature to identify RCTs that investigated clinically relevant outcomes from the use of dietary supplements and then to synthesize and summarize these data.”2

    They focused on RCTs and followed QUORUM group guidelines for systematic review. The broad scope of the study included a search that identified 6,224 studies. Ultimately, 63 studies representing 428,357 patients with a mean duration of 4.7 years qualified for inclusion. To assess benefits across this heterogenous set of studies with varying endpoints, the authors classified the studies in a semiquantitative manner into three categories (non-beneficial, beneficial, harmful) according to whether the endpoint(s) of each study reached statistical significance.

    Supplements were found to be non-beneficial in 71% of studies compared to 21% where they were beneficial, and 8% where they were harmful (see Table 5). Beneficial study results came from five supplements including vitamin E, folic acid, vitamin D, omega-3 fatty acids, and selenium. The authors concluded that except for vitamin D, which had beneficial results in six of 13 studies, and omega-3 fatty acids, which had beneficial results in three of five studies, data does not support the widespread use of supplements.


    A very small proportion of nutraceutical products have any published evidence of clinical benefit. The evidence that exists is skewed to the lower end of the hierarchy of evidence quality. And from the evidence that exists, a large percentage does not show benefit. In these cases, ultimately a clinically and statistically significant benefit may not exist, or it may but the study was not properly designed or adequately powered to detect it.

    Needs and Opportunities
    The needs and opportunities for generating clinical evidence first depends on perspective. We consider consumers, health professionals, and nutraceutical companies.

    A study on consumer preferences and willingness to pay for nutraceuticals provides some insight on the potential value consumers place on evidence. Teoh and colleagues (Value Health Reg Issues, 2021) conducted a discrete choice study with Malaysian consumers and reported that they were willing to pay $100 more for nutraceuticals that had scientific proof of clear effectiveness versus not having that data available.3

    Safety was found to be the most important factor from the 111 participants in the study with an average willingness to pay $221 more for a nutraceutical with scientific proof of no side effect. While this was a robust study, country-specific attribute preferences and willingness to pay have limited generalizability. 

    Increasingly, people are accessing information on their own to make medical decisions. Surveys have shown that more than one-third of Americans self-diagnose when they encounter a health problem and about 70% of American adults consult the internet for a variety of medical information.4

    Health professionals are a varied group (physicians, dietitians, nurses, pharmacists, and others) with different roles, influence, and patient interactions, but they are all trained in the use of evidence for clinical decision-making and patient communication. Further, clinical evidence is the foundation for treatment guidelines of every disease, which gets combined with experience, observations, reasoning, and patient preferences. CRN’s 2019 consumer survey found 49% of non-users of dietary supplements might consider using them if a doctor recommended them (15% if a health professional other than a doctor did).

    From the perspective of the nutraceutical company, are there value propositions and claims of clinical benefit in terms of structure/function that would increase sales through direct influence on consumer choice, or indirectly through health professional recommendations? Considering various types of evidence, study design, and cost, what is the most cost-effective evidence to increase health professional recommendations and consumer purchases?

    When nutraceuticals ultimately improve outcomes and quality of life at a lower cost than alternatives, they have a cost-effective advantage and investment in clinical evidence may have a favorable return on investment.

    References
    1. Dwyer, J., et al. (2018). Dietary Supplements: Regulatory Challenges and Research Resources. Nutrients. 10, 41
    2. Marik, P., et al. (2012). Do Dietary Supplements Have Beneficial Health Effects in Industrialized Nations: What is the Evidence. J Parenter Enteral Nutr. Mar: 36(2): 159-68.
    3. Teoh, S., et al. (2021). Consumer Preferences and Willingness to Pay for Nutraceuticals: A Discrete Choice Experiment. Value Health Reg Issues. 24: 167-172
    4. Hochberg, I., et al. (2020). Assessment of the Frequency of Online Searches for Symptoms Before Diagnosis: Analysis of Archival Data. J Med Internet Res. Mar; 22(3): e15065.


    Greg Stephens, RD, is president of Windrose Partners, a company serving clients in the the dietary supplement, functional food and natural product industries. Formerly vice president of strategic consulting with The Natural Marketing Institute (NMI) and Vice President of Sales and Marketing for Nurture, Inc (OatVantage), he has 25 years of specialized expertise in the nutritional and pharmaceutical industries. His prior experience includes a progressive series of senior management positions with Abbott Nutrition (Ross Products Division of Abbott Laboratories), including development of global nutrition strategies for disease-specific growth platforms and business development for Abbott’s medical foods portfolio. He can be reached at 267-432-2696; E-mail: gregstephens@windrosepartners.com.

    David Wilson has over 25 years of experience in the strategic development of evidence for biopharmaceuticals, medical devices, and nutraceuticals. He has held academic and leadership positions in research and strategic planning, in large companies, small start-ups, CROs, and consulting firms. He brings together strategy and generating evidence of value to support marketing, regulatory, reimbursement and market access. He received an MA in Economics from the University of Iowa and is currently an independent consultant focused on evidence strategy and development. (Contact: Dwilson.esd@gmail.com)
    Related Searches
    • Research
    • Quality & Safety
    • Dietary Supplements
    • Healthcare Trends
    Related Knowledge Center
    • Dietary Supplements
    • Research
    • Quality & Safety
    • Healthcare Trends
    Suggested For You
    Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand
    Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health
    Vitamin D: A Fixture of Supplementation and Fortification Vitamin D: A Fixture of Supplementation and Fortification
    NGS Begins Pilot Trial of Sports Supplement for Children NGS Begins Pilot Trial of Sports Supplement for Children
    Battles That Have United the Natural Products Industry—and Those Which Have Not Battles That Have United the Natural Products Industry—and Those Which Have Not
    The Gut Doctor: Functional Medicine Practitioner Dr. Sonza Curtis Gets Into The Belly of Good Health The Gut Doctor: Functional Medicine Practitioner Dr. Sonza Curtis Gets Into The Belly of Good Health
    Large-Scale Review Breaks Down Cardiovascular Effects of 27 Nutrients Large-Scale Review Breaks Down Cardiovascular Effects of 27 Nutrients
    Manufacturing Gummies: Opportunities for Nutraceuticals and Pharmaceuticals Manufacturing Gummies: Opportunities for Nutraceuticals and Pharmaceuticals
    DSM Reduces Vitamin C Production in China DSM Reduces Vitamin C Production in China
    Menatto Vitamin K2 Ingredient Receives Trademark Registration Menatto Vitamin K2 Ingredient Receives Trademark Registration
    Novella Launches Culture Technology for Botanical Ingredients Novella Launches Culture Technology for Botanical Ingredients
    2023 International Buyers 2023 International Buyers' Guide
    DSM Partners with LBB Specialties for North American Distribution DSM Partners with LBB Specialties for North American Distribution
    Micronutrient Deficiencies ‘More Widespread Than Originally Feared’ Micronutrient Deficiencies ‘More Widespread Than Originally Feared’
    What People Were Reading in October 2022 on NutraceuticalsWorld.com What People Were Reading in October 2022 on NutraceuticalsWorld.com

    Related Features

    • Consumer Trends | Contract Manufacturing | Delivery & Dosage Technologies | Dietary Supplements | Healthcare Trends
      Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand

      Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand

      Manufacturing technologies can help improve therapeutic performance of supplements and health products.
      By Sara Lesina, MBA, General Manager Business Unit Europe, Sirio Europe 02.03.23

    • Bone & Joint Health | Cardiovascular Health | Dietary Supplements | Healthcare Trends | Research | Vitamins
      Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

      Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

      Clinical research is revealing overlooked health benefits of the micronutrient.
      By Mike Montemarano, Associate Editor 01.20.23

    • Bone & Joint Health | Delivery & Dosage Technologies | Dietary Supplements | Immune Function | Research | Vitamins
      Vitamin D: A Fixture of Supplementation and Fortification

      Vitamin D: A Fixture of Supplementation and Fortification

      The most widely-supplemented nutrient continues to prevail in large-scale studies on immunity, healthy aging, and more.
      By Mike Montemarano, Associate Editor 01.20.23


    • Breaking News | Dietary Supplements | Infant & Children's Health | Minerals | Proteins, Peptides, Amino Acids | Research News | Sports Nutrition | Vitamins
      NGS Begins Pilot Trial of Sports Supplement for Children

      NGS Begins Pilot Trial of Sports Supplement for Children

      The blend of essential nutrients, proteins, and amino acids will be tested in children who play soccer for effect on athletic performance.
      01.11.23

    • Dietary Supplements | Regulations | World Markets
      Battles That Have United the Natural Products Industry—and Those Which Have Not

      Battles That Have United the Natural Products Industry—and Those Which Have Not

      Looking back at the Vitamin Volstead Act, DSHEA, Codex, the AER Bill, and MPLs
      By James J. Gormley, Gormley NPI Consulting 01.06.23

    Loading, Please Wait..
    Trending
    • Vitamin D Supplementation Reduces Risk Of Dynapenia
    • NOW Switches To Bottles Made From 100% Post-Consumer Recycled Resin
    • Study Examines Vitamin K2 Content In Cheese
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    • The Functional Chocolate Company Launches Painfree Chocolate
    Breaking News
    • GOED Elects New Board Officers for 2023
    • Aspire Hires Darrec Jones as VP of Business Development
    • Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    • BAPP Paper Reviews Common Adulteration Practices Which Go Undetected
    • CRN Announces Promotions and Welcomes New Staff Member
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2023

    • Healthy, Clean Label Snacks and Nutrition Bars Help Fill Nutrient Gap Cleaved By Modern Lifestyles
    • Magnesium: An Essential Mineral with Many Forms and Functions
    • Vitamin D: A Fixture of Supplementation and Fortification
    • Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health
    • All Eyes on Vision Health
    • Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Coatings World

    Latest Breaking News From Coatings World

    PPG Completes COLORFUL COMMUNITIES Project in Denmark
    10 Partners of the Automotive Industry Form JV, Cofinity-X
    BASF Recognized as Top Company for Supplier Diversity
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Feb. 4
    MO SCI Acquires Assets of 3M’s Advanced Materials Business
    Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lilly 4Q Revenues Down 9% to $7.3B
    Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity
    Steriline Provides Fill-Finish Solution for Berkshire Sterile Manufacturing
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Pacifica Introduces Glow Baby Skincare Line
    Kohl’s Names Tom Kingsbury as Chief Executive Officer
    Mielle Unveils Haircare Bundles Inspired by Amazon Original Series Harlem
    Happi

    Latest Breaking News From Happi

    Next of Us Launches Pair of Hair Care Products
    Ivy Beauty Donates $30,000 to the NAACP in Honor of Black History Month
    Grant Industries Names Mehran Ghadim Sales Manager, Canada
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Pigments, Inkjet Ink Market Reports Top This Week’s Stories
    Roland DGA Announces Key Changes to Leadership Team
    Ball Reports 2022 Results
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    MM Packaging adds first Nilpeter press for Dublin site
    Polytag develops new UV tag reading technology
    Enterprise Print Group adds Screen Truepress Jet L350UV SAI E
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    What You’re Reading on Nonwovens-Industry.com
    Kimberly-Clark Supports Period Poverty Initiative in Australia
    Suominen Reports Q4, Full Year Results
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Feb. 4
    Toetal Solutions Secures $1.8 Million in New Financing
    Adrian Tyndall Joins Axogen's Board of Directors
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: CES 2023, ams OSRAM and Celanese Top This Week’s Stories
    Zebra Provides East West Shrine Bowl with RFID Tracking Technology
    AAAS Elects Three ORNL Scientists as Fellows

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login